|
|
|
|
|
|
|
|
|
Wednesday November 2, 2005
|
|
7:15 am
|
|
|
8:15 am
|
The increasing costs associated with pharmaceutical benefits have prompted employers to focus more attention on managing the pharmacy benefit within a consumer-centric plan design. These programs, implemented effectively, have the potential to reduce prescription drug spending among employees while lowering and/or maintaining the overall medical trend of the organization. Additionally, a successful consumer-centric pharmacy benefit model is dependent on innovative pharmacy products that encourage employee buying, education and ownership of their healthcare. Attendees of this seminar will learn about:
- Recent developments and an update of legislative trends, regulations on HSAs
- Encourage lower and proper utilization while not discouraging compliance and adherence
- Explore innovations in drug benefit design by separating medications by therapeutic indication rather than by class
- Evaluate how HRA and HSA offerings can compliment and impact consumer-directed pharmacy initiatives
- Discover how mail order pharmacies and integrating debit cards into CDH programs can lead to overall healthcare cost savings
- Overcoming Administrative Management Hurdles of Payment Systems and Debit Cards Implementation
|
|
|
|
|
9:30 am
|
|
|
11:15 am
|
|
|
Darlene C. Collins
Managing Director
Psilos Group Managers
|
| Darlene Collins is a strategic consultant, CEO, and former Medicaid director with over 15 years executive experience helping state and federal agencies, research firms, private corporations, and nonprofit organizations evaluate and respond to market intelligence, emerging health care trends and government policy initiatives. Since April 2000, she serves as management consultant to the National Governors Association, Center for Best Practices in Washington D.C., where she is an advisor and faculty to the NGA Policy Academy on Chronic Disease Prevention and Management, which has provided technical assistance to 25 states. Ms. Collins is the author of national policy issue briefs with current research focusing on market trends and best practices targeting health benefit design, pharmaceutical costs and use, and disease management models for employee/retirees, Medicaid and Medicare populations led by state and federal government, private sector companies and business coalitions.
|
|
|
|
|
|
|
|
|
 |
|
|